ZK (ZKsync) fluctuated 56.8% in 24 hours: Low liquidity drives sharp price volatility
Bitget Pulse2026/05/08 12:03Volatility Overview
Over the past 24 hours, ZK rebounded from a low of $0.01152 to a high of $0.01806, currently quoted at $0.01427, with a price fluctuation amplitude of 56.8%. The 24-hour trading volume is approximately $31.4 million.
Brief Analysis of Movement Reasons
- The low liquidity market environment has resulted in thin order books amplifying price volatility, similar to previously reported cases where ZK experienced a 57.9% fluctuation within 24 hours.
- On May 7, ZKsync announced the launch of its protocol fee management system, allowing users to use ZK tokens to purchase and claim accumulated fees (such as USDC, ETH). This forms a community-driven buyback and burn mechanism, stimulating short-term speculative interest.
Market Views and Outlook
Overall community sentiment is bullish, with CoinMarketCap voting showing 81% bullishness. Discussion focuses on bottom-rebound and breakout potential (e.g., the $0.020 target). The latest posts on X highlight the ZKsync Prividium privacy upgrade and institutional adoption potential, though in the short term, caution is advised regarding high RSI overbought risks and the potential for pullbacks caused by low liquidity.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Hundred Billion ARR and 18.4 Billion Burn Rate: SpaceX (SPCX.US) First Quarterly Report Faces Off Between "Growth and Cost"
After the U.S. stock market closed on August 4, SpaceX released its first quarterly report since going public. Despite second-quarter revenue doubling significantly and management providing strong guidance to reach $100 billion ARR by the end of the year, the company's stock price plunged by more than 9% after hours.
Dogecoin: Is DOGE’s record-low RSI a buy signal or bull trap?
Novo Nordisk (NVO.US) Q2 results beat expectations and full-year guidance is raised, but concerns remain! Wegovy oral drug sales are weak, and the path to renewed growth is still uncertain
Although Novo Nordisk reported better-than-expected Q2 2026 results and raised its full-year guidance, it did not address the issue that is of most concern to Wall Street.
Biconomy Price Prediction: BICO Surges 126% Weekly as Bulls Target $0.03
Crypto prices
More
